yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q39588193-1504B64A-C181-441E-8244-EE419A399C77
Q39588193-1504B64A-C181-441E-8244-EE419A399C77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39588193-1504B64A-C181-441E-8244-EE419A399C77
Emergence of CXCR4-using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir.
P2860
Q39588193-1504B64A-C181-441E-8244-EE419A399C77
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39588193-1504B64A-C181-441E-8244-EE419A399C77
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fc729fbd09330e072c890ceab3afca9ffcedc5cd
P2860
Early protective effect of CCR-5 delta 32 heterozygosity on HIV-1 disease progression: relationship with viral load. The SEROCO Study Group.